Contact this trialFirst, we need to learn more about you.
Hormone Therapy
ARV-471 + Everolimus for Advanced Breast Cancer
Recruiting1 awardPhase 1
Santa Monica, California
This trial tests a new drug combination (ARV-471 and everolimus) for patients with advanced or metastatic ER+/HER2- breast cancer who have already tried other treatments. The drugs work together to slow down cancer growth by targeting estrogen receptors and blocking a growth pathway. Everolimus is used in combination with other treatments for advanced hormone-receptor-positive, HER2-negative breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service